Cancer Chemoprevention E-bok

Part I. Chemopreventive Agent Development Science; Characterization of Chemopreventive Agents in Natural Products; John M. Pezzuto, Jerome W. Kosmeder, II, Eun Jung Park, Sang Kook Lee, Muriel Cuendet, Joell Gills, Krishna Bhat, Simonida Grubjesic, Hye-Sung Park, Eugenia Mata-Greenwood, YingMeei Tan, Rong Yu, Daniel D. Lantvit, and A. Douglas Kinghorn; Preclinical Animal Models for the Development of Cancer Chemoprevention Drugs; Vernon E. Steele, Ronald A. Lubet, and Richard C. Moon; Potential Use of Transgenic Mice in Chemoprevention Studies; Ronald A. Lubet, Jeffrey Green, Vernon Steele, and Ming You; Modeling Human Colorectal Cancer in Mice for Chemoprevention Studies; Martin Lipkin and Sergio A. Lamprecht; Pathology of Incipient Neoplasia; Donald Earl Henson and Jorge Albores-Saavedra; Quantitative Nuclear Grade: Clinical Applications of the Quantitative Measurement of Nuclear Structure Using Image Analysis; Robert W. Veltri, Alan W. Partin, and M. Craig Miller; Enabling Discovery through Online Cancer Genome Databases and Analytic Tools; Robert L. Strausberg and Gregory J. Riggins; Functional Genomics for the Identification of Surrogate Endpoint Biomarkers in Breast Cancer Chemoprevention; Melissa A. Troester and Charles M. Perou; Clinical Applications of Proteomics; Emanuel F. Petricoin and Lance A. Liotta; Bioinformatics and Whole Genome Technologies; Richard Simon; Models of Absolute Risk: Uses, Estimation, and Validation; Mitchell H. Gail; Genetic Polymorphisms and Risk Management for Cancer Chemoprevention; Sonia de Assis and Peter G. Shields; Design Issues in Prostate Cancer Chemoprevention Trials: Lessons from the Prostate Cancer Prevention Trial; Ian M. Thompson and Charles A. Coltman, Jr.; Recruitment Strategies for Cancer Prevention Trials; Paul P. Carbone, Karen Sielaff, Mary Hamielec, and Howard Bailey; Part II. Cancer Chemoprevention at Major Cancer Target Sites; Prostate; Prostate Cancer Prevention; William G. Nelson, Angelo M. de Marzo, and Scott M. Lippman; Use of PSA to Evaluate Rick and Progression of Prostate Cancer; Bulent Akduman, Abelardo Errejon, and E. David Crawford; Breast; Clinical Approaches to Discovery and Testing of New Breast Cancer Prevention Drugs; Carol J. Fabian, Bruce F. Kimler, Matthew S. Mayo, William E. Grizzle, Shahla Masood, and Giske Ursin; Ductal Lavage: Its Role in Breast Cancer Risk Assessment and Risk Reduction; Joyce O'Shaughnessy and Andrea Decensi; Counteracting Estrogen as Breast Cancer Prevention; Kathrin Strasser-Weippl and Paul E. Goss; Colorectal; Chemoprevention of Colorectal Cancer: Clinical Strategies; Monica M. Bertagnolli and Stanley R. Hamilton; Screening in Risk Evaluation and Prevention of Colorectal Cancer; Bernard Levin; Lung; Strategies in Lung Cancer Chemoprevention; Edward S. Kim, Faye M. Johnson, Waun Ki Hong, and Fadlo R. Khuri; Lung Cancer Chemoprevention: An Opportunity for Direct Drug Delivery; James L. Mulshine and Luigi M. De Luca; Bladder; Bladder Cancer: Clinical Strategies for Cancer Chemoprevention; H. Barton Grossman, Anita L. Sabichi, and Yu Shen; Esophagus; Barrett's Esophagus: Strategies for Cancer Prevention; Brian J. Reid; Endoscopic Detection of Esophageal Neoplasia; Brian C. Jacobson and Jacques Van Dam